ArticleAAPS PharmSciTech2026
Design and Optimization of Indomethacin Nanocrystals using Machine Learning and Molecular Dynamics Simulations.
Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a stable nanocrystalline drug delivery system for indomethacin (IND) was rapidly developed by integrating machine learning methods with Hummer Acoustic Resonance (HAR) technology. This system effectively enhanced the solubility of IND and demonstrated excellent scalability. High-throughput screening using HAR technology identified P188-PVA as the optimal composite stabilizer for IND nanocrystal suspensions. Molecular dynamics simulations were employed to thoroughly investigate the interaction mechanisms between the drug and stabilizers. Systematic design and optimization of IND nanocrystal formulation parameters and HAR process conditions were conducted using an integrated modeling approach combining Box-Behnken design (BBD) and artificial neural networks (ANN). Various statistical metrics were employed to evaluate and compare the predictive accuracy and generalization capability of BBD-RSM and ANN models, thereby identifying the optimal formulation. HAR technology was successfully used to scale up the optimal formulation by 5- and 50-fold, demonstrating its initial potential for scalability. Freeze-drying, spray-drying, and fluidized-bed drying techniques were evaluated for solidifying the prepared nanocrystal suspensions. Multiple analytical techniques were employed to characterize the particle size and solid-state properties of IND nanocrystals. PXRD and DSC analyses confirmed the crystalline nature of the IND nanocrystals. In vitro dissolution experiments indicated that IND nanocrystals exhibited significantly improved dissolution compared to raw IND. Additionally, the concepts and methodologies proposed in this study could also be applied to the development of other poorly water-soluble drugs.
Indexed as
Identifiers
41781640What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.